Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

The day has come: Merck’s Keytruda surpasses Bristol-Myers Squibb’s Opdivo in Q2 sales

fiercepharmaJuly 30, 2018

Tag: Keytruda , Bristol-Myers Squibb , Opdivo

PharmaSources Customer Service